Cisplatin-topotecan-paclitaxel weekly administration with G-CSF support for ovarian and small-cell lung cancer patients: A dose-finding study

Annals of Oncology

Volumn 10, Issue 3, 1999, Pages 355-358

  Frasci, G ^a,b   Panza, N ^a   Comella, P ^a   Carteni G ^a   Guida, T ^a   Nicolella, G P ^a   Natale, M ^a   Lombardi, R ^a   Apicella, A ^a   Pacilio, C ^a   Gravina, A ^a   Lapenta, L ^a   Comella, G ^a  

^a CARDARELLI HOSPITAL   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Cisplatin; Ovarian cancer; Paclitaxel; Small cell lung cancer; Topotecan; Weekly regimen

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; PACLITAXEL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TOPOTECAN;

ADULT; AGED; ALOPECIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; DOSE CALCULATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG SMALL CELL CANCER; MALE; NAUSEA; NEUTROPENIA; OVARY CANCER; PRIORITY JOURNAL; THROMBOCYTOPENIA; VOMITING;

EID: 0032910847     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008301222560     Document Type: Article

References (16)

1. McGuire WP, Hoskins WJ, Brady MF et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and IV ovarian cancer. N Engl J Med 1996; 334: 1-6.
2. Nair S, Marschke R, Grill J et al. A phase II study of paclitaxel and cisplatin in the treatment of extensive stage small-cell lung cancer. Proc Am Soc Clin Oncol 1997; 16: 454a (Abstr 1629).
3. Creemers GJ, Bolis G, Gore M et al. Topotecan, an active drug in the second-line treatment of epithelial ovarian cancer: Results of a large European phase II study. J Clin Oncol 1996; 14: 3056-61.
4. ten Bokkel-Huinink W, Gore M, Carmichael J et al. Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer. J Clin Oncol 1997; 15: 2183-93.
5. Schiller JH, Kim K, Hutson Petal. Phase II study of topotecan in extensive stage Small Cell carcinoma of the lung: An Eastern Cooperative Oncology Group Trial. J Clin Oncol 1996; 14: 2345-52.
6. Rowinsky EK, Kaufmann SH, Baker SD et al. Sequences of topotecan and cisplatin: phase I pharmacologic and in vitro studies to examine sequence dependence. J Clin Oncol 1997; 15: 3074-84.
7. O'Reilly S, Fleming GF, Baker SD et al. Phase I trial and pharmacologic trial of sequences of paclitaxel and topotecan in previously treated ovarian epithelial malignancies: A Gynecologic Oncology Group study. J Clin Oncol 1997; 15: 177-86.
8. Raefsky EL, Hainsworth JD, Burris HA, Hopkins LG, Greco FA. Phase I trial of topotecan, paclitaxel and carboplatin in patients with advanced refractory malignancies. Proc Am Soc Clin Oncol 1998; 17: 498a (Abstr 1920).
9. ten Bokkel-Huinink WW, Richel DJ, Herben VMM et al. Feasibility study of the combination of cisplatin, paclitaxel and topotecan in ovarian cancer patients. Proc Am Soc Clin Oncol 1998; 17: 351a (Abstr 1353).
10. Akerley W, Glantz M, Choy H et al. Phase I trial of weekly paclitaxel in advanced lung cancer. J Clin Oncol 1998; 16: 153-8.
11. Frasci G, Comella P, D'aiuto G et al. Weekly paclitaxel-cisplatin administration with G-CSF support in advanced breast cancer. A phase II study. Breast Cancer Res Treat 1998; 49: 13-26.
12. van der Burgh MEL, de Wit R, Stoter G, Verweij J. Phase I study of weekly cisplatin and weekly or four-weekly Taxol: A highly active regimen in advanced epithelial ovarian cancer. Proc Am Soc Clin Oncol 1998; 17: 355a (Abstr 1370).
13. Miller AA, Hargis JB, Lilenbaum RC et al. Phase I study of topotecan and cisplatin in patients with advanced solid tumors. J Clin Oncol 1994; 12 (12): 2743-50.
14. Jett JR, Day R, Levitt M, Woolley G, Jacobs S. Topotecan and paclitaxel in extensive stage small-cell lung cancer patients without prior therapy. Lung Cancer 1997; 18 (Suppl 1): 13 (Abstr 38).
15. Haas NB, LaCreta FP, Walczak J et al. Phase I/pharmacokinetic study of topotecan by 24-hour continuous infusion weekly. Cancer Res 1994; 54: 1220-6.
16. Eisenhauer E, Hoskins P, Beare S et al. Randomized phase II study of two schedules of topolecan in previously treated epithelial ovarian cancer. Proc Am Soc Clin Oncol 1997; 16: 349a (Abstr 1249).